[1] |
Ciardiello F, Ciardiello D, Martini G, et al. Clinical management of metastatic colorectal cancer in the era of precision medicine[J]. CA Cancer J Clin, 2022, 72(4): 372-401.
|
[2] |
Jin M, Frankel WL. Lymph node metastasis in colorectal cancer[J]. Surg Oncol Clin N Am, 2018, 27(2): 401-412.
|
[3] |
Veronese N, Nottegar A, Pea A, et al. Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: a systematic review with meta-analysis[J]. Ann Oncol, 2016, 27(1): 42-48.
|
[4] |
Agarwal P, Le DT, Boland PM. Immunotherapy in colorectal cancer[J]. Adv Cancer Res, 2021, 151: 137-196.
|
[5] |
Ganesh K. Optimizing immunotherapy for colorectal cancer[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(2): 93-94.
|
[6] |
Lichtenstern CR, Ngu RK, Shalapour S, et al. Immunotherapy, inflammation and colorectal cancer[J]. Cells. 2020, 9(3): 618.
|
[7] |
Chang JE, Turley SJ. Stromal infrastructure of the lymph node and coordination of immunity[J]. Trends Immunol, 2015, 36(1): 30-39.
|
[8] |
du Bois H, Heim TA, Lund AW. Tumor-draining lymph nodes: at the crossroads of metastasis and immunity[J]. Sci Immunol, 2021, 6(63): eabg3551.
|
[9] |
Kim R, Emi M, Tanabe K, et al. Immunobiology of the sentinel lymph node and its potential role for antitumour immunity[J]. Lancet Oncol, 2006, 7(12): 1006-1016.
|
[10] |
Wang Y, Wang H. Lymph node targeting for immunotherapy[J]. Immunooncol Technol, 2023, 20: 100395.
|
[11] |
Apollonio B, Spada F, Petrov N, et al. Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma[J]. J Clin Invest, 2023, 133(13): e166070.
|
[12] |
Choi Y, Lichterman JN, Coughlin LA, et al. Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity[J]. Sci Immunol, 2023, 8(81): eabo2003.
|
[13] |
Prokhnevska N, Cardenas MA, Valanparambil RM, et al. CD8(+) T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor[J]. Immunity, 2023, 56(1): 107-124.e5.
|
[14] |
Rahim MK, Okholm TLH, Jones KB, et al. Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes[J]. Cell, 2023, 186(6): 1127-1143.e18.
|
[15] |
张明光, 王锡山. 结直肠外科术式的发展历程及挑战[J].中华医学杂志, 2021, 101(44): 3620-3624.
|
[16] |
王卫东, 郎锦义. 免疫治疗时代肿瘤区域淋巴结处理的再思考—免疫功能精准防护迫在眉睫[J]. 肿瘤预防与治疗, 2020, 33(1): 1-4.
|
[17] |
Eklind S, Lindfors A, Sjöli P, et al. A prospective, comparative study on robotic versus open-surgery hysterectomy and pelvic lymphadenectomy for endometrial carcinoma[J]. Int J Gynecol Cancer, 2015, 25(2): 250-256.
|
[18] |
王锡山. 直肠癌选择性扩大根治术的必要性[J].中华胃肠外科杂志, 2009, 12(3): 221-223.
|
[19] |
国家卫生健康委员会医政司, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2023版) [J].协和医学杂志, 2023, 14(4): 706-733.
|
[20] |
王治杰, 刘骞. 直肠和乙状结肠癌区域淋巴结清扫的规范化开展[J]. 中华胃肠外科杂志, 2022, 25(4): 309-314.
|
[21] |
安柯, 顾晋. 直肠癌侧方淋巴结的概念与侧方淋巴结清扫的争议[J]. 中华胃肠外科杂志, 2022, 25(8): 694-698.
|
[22] |
何金杰, 丁克峰. 腹腔镜结直肠癌手术的质量控制[J]. 中华胃肠外科杂志, 2015(8): 759-762.
|
[23] |
刘荫华, 姚宏伟. 结直肠癌外科手术的原则与进展[J]. 中华消化外科杂志, 2013, 12(6): 401-404.
|
[24] |
曾利武, 杜雨强, 张鹏, 等. 直肠癌侧方淋巴结转移的影像评估进展[J]. 国际肿瘤学杂志, 2023, 50(4): 248-251.
|
[25] |
颜智敏, 冯智超, 曹鹏, 等. 多层螺旋CT图像纹理分析对直肠癌转移性淋巴结的诊断价值[J]. 中华放射学杂志, 2017, 51(6): 432-436.
|
[26] |
Guan X, Zhao Z, Yang M, et al. Whether partial colectomy is oncologically safe for patients with transverse colon cancer: a large population-based study[J]. Oncotarget, 2017, 8(54): 93236-93244.
|
[27] |
Guan X, Cheng P, Wei R, et al. Enlarged tumour-draining lymph node with immune-activated profile predict favourable survival in non-metastatic colorectal cancer[J]. Br J Cancer. 2023 Nov 13.
|
[28] |
Grant SM, Lou M, Yao L, et al. The lymph node at a glance-how spatial organization optimizes the immune response[J]. J Cell Sci, 2020, 133(5): jcs241828.
|
[29] |
Mowat AM, Agace WW. Regional specialization within the intestinal immune system[J]. Nat Rev Immunol, 2014, 14(10): 667-685.
|
[30] |
Kuraoka M, Yeh CH, Bajic G, et al. Recall of B cell memory depends on relative locations of prime and boost immunization[J]. Sci Immunol, 2022, 7(71): eabn5311.
|
[31] |
Gasteiger G, Ataide M, Kastenmüller W. Lymph node - an organ for T-cell activation and pathogen defense[J]. Immunol Rev, 2016, 271(1): 200-220.
|
[32] |
Hampton HR, Chtanova T. The lymph node neutrophil[J]. Semin Immunol, 2016, 28(2): 129-136.
|
[33] |
Neeland MR, Meeusen EN, de Veer MJ. Afferent lymphatic cannulation as a model system to study innate immune responses to infection and vaccination[J]. Vet Immunol Immunopathol, 2014, 158(1-2): 86-97.
|
[34] |
Cao LL, Kagan JC. Targeting innate immune pathways for cancer immunotherapy[J]. Immunity, 2023, 56(10): 2206-2217.
|
[35] |
Deng H, Zhou J, Chen H, et al. Impact of lymphadenectomy extent on immunotherapy efficacy in post-resectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study[J]. Int J Surg, 2023 Sep 27.
|
[36] |
Fransen MF, Schoonderwoerd M, Knopf P, et al. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy[J]. JCI Insight, 2018, 3(23): e124507.
|